EUVIMEDEUVIMED entdecken
Crossref

Assessing Medicare’s Coverage With Evidence Development Program

Maryam Mooghali, Osman Moneer, Guneet Janda, Sanket S Dhruva, Joseph S Ross, Reshma Ramachandran

Health Affairs · 2025

DOI: 10.1377/hlthaff.2024.00814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2025. Verfasst von Maryam Mooghali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Maryam Mooghali (maryam.mooghali@yale.edu), Yale University, New Haven, Connecticut. Hauptthemen laut MEDLINE: Medicare, Centers for Medicare and Medicaid Services, U.S.. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: Arnold Ventures.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Centers for Medicare and Medicaid Services (CMS) coverage with evidence development (CED) program provides coverage for items and services not meeting Medicare's "reasonable and necessary" standard while requiring participation in clinical studies. As additional evidence is available, CMS may reconsider CED decisions. Of twenty-six items and services in the CED program since its 2005 inception, CMS has reconsidered coverage for ten (38 percent). Of 235 publications that CMS cited as evidence supporting reconsideration, 57 (24 percent) were CED-approved studies, and 116 (49 percent) were non-CED-approved studies. Compared with non-CED-approved studies, CED-approved studies had more robust designs (67 percent versus 13 percent randomized clinical trials), larger enrollment (median sample size of 1,000 versus 125), and more frequent inclusion of US patients (93 percent versus 44 percent). CMS's reliance on non-CED-approved studies for CED reconsiderations, despite CED-approved studies being higher quality and more representative of Medicare beneficiaries, highlights opportunities to strengthen the CED program.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedicareCenters for Medicare and Medicaid Services, U.S.United StatesHumansEvidence-Based MedicineInsurance CoverageClinical Trials as Topic

Autor:innen und Institutionen

  • Maryam Mooghali (maryam.mooghali@yale.edu), Yale University, New Haven, Connecticut.
  • Osman Moneer, Stanford University, Stanford, California.
  • Guneet Janda, Mayo Clinic, Rochester, Minnesota.
  • Sanket S. Dhruva, University of California San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California.
  • Joseph S. Ross, Yale University.
  • Reshma Ramachandran, Yale University.

Förderung

  • Arnold Ventures

Zitieren

APA

Mooghali, M., Moneer, O., Janda, G., Dhruva, S. S., Ross, J. S., & Ramachandran, R. (2025). Assessing Medicare’s Coverage With Evidence Development Program. Health Affairs. https://doi.org/10.1377/hlthaff.2024.00814

Vancouver

Mooghali M, Moneer O, Janda G, Dhruva SS, Ross JS, Ramachandran R. Assessing Medicare’s Coverage With Evidence Development Program. Health Affairs. 2025. doi:10.1377/hlthaff.2024.00814

BibTeX
@article{Mooghali2025,
  author = {Mooghali, Maryam and Moneer, Osman and Janda, Guneet and Dhruva, Sanket S and Ross, Joseph S and Ramachandran, Reshma},
  title = {Assessing Medicare’s Coverage With Evidence Development Program},
  journal = {Health Affairs},
  year = {2025},
  doi = {10.1377/hlthaff.2024.00814}
}
Kostenlos starten →